Immunization With NY-ESO-1 Protein Combined With CpG 7909 in Patients With Prostate Cancer
Clinical trial NCT00292045 · COMPLETED
Trial details
- NCT number
- NCT00292045
- Sponsor
- Ludwig Institute for Cancer Research
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-27
- Primary completion
- 2006-01-09
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.